Propylthiouracil Production Cost Reports

The report provides a detailed analysis essential for establishing a propylthiouracil production plant. It encompasses all critical aspects necessary for propylthiouracil production, including the cost of propylthiouracil production, propylthiouracil plant cost, propylthiouracil production costs, and the overall propylthiouracil production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a propylthiouracil production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Propylthiouracil is an antithyroid drug that is used to manage hyperthyroidism by stopping the enzyme thyroid peroxidase. This blocks the synthesis of thyroid hormones T3 and T4 in the thyroid gland, thereby reducing excessive hormone production. It is used in the treatment of conditions like Graves' disease, toxic multinodular goitre and toxic adenoma, mainly in patients who experience adverse reactions to the preferred first-line agent methimazole. It is also utilised to prepare patients for thyroidectomy by normalising thyroid function and preventing thyroid storm during surgery. It serves as adjunctive therapy alongside radioactive iodine (RAI) ablation to control symptoms rapidly. Its common side effects include rash, itching, hives, abnormal hair loss, skin pigmentation changes, nausea, vomiting, heartburn, etc.

The market for propylthiouracil is fuelled by the rising global cases of thyroid disorders like hyperthyroidism and Graves' disease. The rise in the ageing population, enhanced diagnostic capabilities, and greater endocrine health awareness contribute to its demand. Its usage in first-trimester pregnancy, thyroid storm, or methimazole intolerance, along with regulatory support, medical guidelines, and R&D into safer formulations, fuels its demand. The industrial propylthiouracil procurement is influenced by the presence of generic manufacturers that dominate supply and exert pricing pressures through competition and substantial generic penetration. The monitoring protocols, shifts to alternatives, regional variations in healthcare infrastructure, and regulatory approvals impact its sourcing.

Raw Material for Propylthiouracil Production

According to the propylthiouracil production plant project report, the key raw materials used in the production of propylthiouracil include methyl 3-oxohexanoate and thiourea.

Production Process of Propylthiouracil

The extensive propylthiouracil production cost report consists of the following major industrial production process:

1. From condensation reaction: The production process of propylthiouracil uses a one-pot condensation reaction. In this process, thiourea is dissolved in deionised water with potassium carbonate. This is followed by the addition of methyl 3-oxohexanoate, and the mixture is heated. This is then cooled, diluted with water, and acidified with concentrated HCl to precipitate the crude product. The product is collected by vacuum filtration, washed with cold water, and dried to get propylthiouracil.

Propylthiouracil has the molecular formula of C7H10N2OS with a molecular weight of 170.23 g/mol. It is a white to pale-cream crystalline powder or microcrystalline solid that is very slightly soluble in water. It requires protection from light to maintain stability. It has a melting point of 219–221  degree Celsius with low vapour and a value of around 0.42, which makes it moderately lipophilic. It works as a thiourea derivative that inhibits thyroid peroxidase, exists in tautomeric forms, and shows solubility characteristics enhanced in alkaline conditions because of its weakly acidic nature (pKa around 7.8).